文献速递腹部CT

胆道癌CT影像组学模型:预测淋巴结转移与生存结局

Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes.
PubMed 文献 · Radiology · 2018-10-16

本研究基于177例胆道癌切除并淋巴结清扫患者的门静脉期CT建立影像组学模型,内部验证70例,模型预测淋巴结转移的AUC在主队列为0.81、验证队列为0.80;高风险患者术后疾病特异性生存和無复发生存均较低,高风险淋巴结转移是术前独立预测因子。

要点

  • 基于门静脉期CT的三特征影像组学标签与淋巴结转移相关(主队列和验证队列均P < .001)。
  • 影像组学列线图预测淋巴结转移的AUC在主队列为0.81、验证队列为0.80。
  • 高风险淋巴结转移患者术后疾病特异性生存和無复发生存均较低(均P < .001)。

核心结论

  • 基于肝脏门静脉期CT的影像组学模型对胆道癌淋巴结转移具有良好预测性能,可能有助于改善临床决策。

研究设计与样本

  • 回顾性研究,主队列纳入2010年6月至2016年12月间接受切除和淋巴结清扫的177例胆道癌患者,用于建立影像组学模型。
  • 从门静脉期CT扫描中提取影像组学特征,采用最小绝对收缩和选择算子法基于可重复特征构建影像组学标签。
  • 采用多变量逻辑回归建立影像组学列线图,并通过区分度、校准度和临床实用性评估列线图性能。
  • 模型在2017年1月至2018年2月间连续纳入的70例胆道癌患者中进行内部验证。

诊断标准与关键数值

  • 影像组学标签由三个与淋巴结状态相关的特征组成,在主队列和验证队列中均与淋巴结转移相关(P < .001)。
  • 整合影像组学标签和CT报告的淋巴结状态的影像组学列线图在主队列中AUC为0.81、验证队列中AUC为0.80,校准度和区分度良好。
  • 高风险淋巴结转移是疾病特异性生存的独立术前预测因子(风险比3.37;P < .001)和無复发生存的独立术前预测因子(风险比1.98;P = .003)。

临床应用与阅片要点

  • 基于门静脉期CT提取的三个淋巴结状态相关影像组学特征可用于构建预测胆道癌淋巴结转移的影像组学标签。
  • 整合影像组学标签与CT报告的淋巴结状态构建的列线图在主队列AUC为0.81、验证队列AUC为0.80,可作为术前预测淋巴结转移的参考。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate a radiomics model for predicting lymph node (LN) metastasis in biliary tract cancers (BTCs) and to determine its prognostic value for disease-specific and recurrence-free survival. Materials and Methods For this retrospective study, a radiomics model was developed on the basis of a primary cohort of 177 patients with BTC who underwent resection and LN dissection between June 2010 and December 2016. Radiomic features were extracted from portal venous CT scans. A radiomics signature was built on the basis of reproducible features by using the least absolute shrinkage and selection operator method. Multivariable logistic regression model was adopted to establish a radiomics nomogram. Nomogram performance was determined by its discrimination, calibration, and clinical usefulness. The model was internally validated in 70 consecutive patients with BTC between January 2017 and February 2018. Results The radiomics signature, composed of three LN-status-related features, was associated with LN metastasis in primary and validation cohorts (P < .001). The radiomics nomogram that incorporated radiomics signature and CT-reported LN status showed good calibration and discrimination in primary cohort (area under the curve, 0.81) and validation cohort (area under the curve, 0.80). Patients at high risk of LN metastasis portended lower disease-specific and recurrence-free survival than did those at low risk after surgery (both P < .001). High-risk LN metastasis was an independent preoperative predictor of disease-specific survival (hazard ratio, 3.37; P < .001) and recurrence-free survival (hazard ratio, 1.98; P = .003). Conclusion A radiomics model derived from portal phase CT of the liver has good performance for predicting lymph node metastasis in biliary tract cancer and may help to improve clinical decision making. © RSNA, 2018 Online supplemental material is available for this article. See also the editorial by Laghi and Voena in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Ji GW, Zhang YD, Zhang H, et al. Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes. Radiology. 2018. PMID: 30325283. doi:10.1148/radiol.2018181408

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。